Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Not yet recruiting 2

Sponsor Class

OTHER 3NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Central Nervous System Neoplasms 38Head and Neck Neoplasms 32Lung Neoplasms 31Squamous Cell Carcinoma of Head and Neck 28Lymphoma 27Carcinoma, Non-Small-Cell Lung 23Prostatic Neoplasms 21Breast Neoplasms 18Brain Neoplasms 18Leukemia 15Glioblastoma 15Sarcoma 13Gliosarcoma 13Uterine Cervical Neoplasms 12Astrocytoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Adenocarcinoma of Lung 11Burkitt Lymphoma 10Rhabdomyosarcoma 9Neoplasm Metastasis 9Lymphoma, Large B-Cell, Diffuse 9Hodgkin Disease 9Rectal Neoplasms 8Radiation Injuries 8Oligodendroglioma 8Esophageal Neoplasms 8Colorectal Neoplasms 8Adenocarcinoma Of Esophagus 8Urinary Bladder Neoplasms 6Stomach Neoplasms 6

Interventions

Radiotherapy 2Gemcitabine 2Docetaxel 1BCG Vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Non-Muscle Invasive Bladder Neoplasms × Radiotherapy × Clear all
NCT06990061 2025-05-25

BRACE

European Organisation for Research and Treatment of Cancer - EORTC

Phase NA Not yet recruiting
50 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT06310369 2024-07-22

Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Not yet recruiting
50 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡